Colo-rectal CancerShared Decision MakingPatient Decision Aid
Investigational drug(s) / intervention(s)
ColonoscopyShared Decision-Making
Colonoscopy: Participants underwent standard colonoscopy performed by experienced endoscopists following routine clinical procedures.
Shared Decision-Making: Participants received a shared decision-making intervention including educational materials and discussion with clinicians to choose between screening options.
Study summary
The primary objective of this study was to evaluate the impact of a constructed shared decision (SDM) intervention (offering an option between colonoscopy and immunochemical collapsible occult blood testing (fecal immunochemical test; FIT)) on improving the incidence of high colonoscopy stromal in patients aged 40-49 years with a close relative suffering from colorectal cancer, compared to standard care (direct referral for colonoscopy).
Eligibility
Sex
ALL
Min age
40 Years
Max age
49 Years
Healthy volunteers
No
Inclusion Criteria:
* Age 40 to 49 years at the time of recruitment.
* At least one immediate family member (biological parent, sibling, or child) has been pathologically diagnosed with colorectal cancer.
* Able to read, understand, and provide prior consent.
* Willing to be randomly assigned to any research group and complete all research procedures.
Exclusion Criteria:
* A personal history of colorectal cancer or inflammatory bowel disease (Crohn's disease or ulcerative colitis).
* Presence of warning signs of colorectal cancer requiring diagnostic evaluation rather than screening (e.g., unexplained rectal bleeding, significant involuntary weight loss, persistent changes in bowel habits).
* Presence of comorbidities that may contraindicate colonoscopy.
* Having undergone colonoscopy within the past three years.
* Inability to read, understand, and provide written informed consent.
Primary outcome measure(s)
Colonoscopy screening rate — Within 3 months after randomization Completion of colonoscopy within 3 months after randomization, defined as documented completion of colonoscopy or colonoscopy performed after a positive FIT result.
Trial sites (1)
Facility
City
Region
Status
National Taiwan University Hospital
Taipei
Taiwan
More National Taiwan University Hospital trials in Taiwan
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.